Literature DB >> 8601842

The C-terminal domain of cartilage matrix protein assembles into a triple-stranded alpha-helical coiled-coil structure.

K Beck1, J E Gambee, C A Bohan, H P Bächinger.   

Abstract

Cartilage matrix protein (CMP) is a major component of different cartilages and consists of a disulfide-linked homotrimer. To test whether the C-terminal region forms a three-stranded alpha-helical coiled-coil, we synthesized a peptide, CMP-C36, corresponding to the last 36 residues of human CMP. Analytical ultracentrifugation revealed that CMP-C36 forms a homotrimer under physiological conditions. The sedimentation coefficient of 1.12 S is consistent with a rod-shaped molecule of 5.8 nm length, suggesting a lateral packing of three peptide chains. Depending on conditions, circular dichroism spectroscopy showed 75 to 96% alpha-helical content. The shapes of the spectra are characteristic for a coiled-coil structure. Thermal and guanidine-HCI-induced denaturation revealed a high degree of cooperativity and high stability. The concentration dependence of the melting temperature suggest a two-state transition. The trimer is stabilized by increasing the ionic strength above 130 mM salt, above which six ions are released upon unfolding. The peptide characteristics make it very likely that the C-terminal domain serves as the trimerization site of CMP. The two cysteine residues preceding this sequence region might stabilize the complex after assembly.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8601842     DOI: 10.1006/jmbi.1996.0137

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  10 in total

1.  A single amino acid can switch the oligomerization state of the alpha-helical coiled-coil domain of cartilage matrix protein.

Authors:  K Beck; J E Gambee; A Kamawal; H P Bächinger
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

2.  Assembly of a novel cartilage matrix protein filamentous network: molecular basis of differential requirement of von Willebrand factor A domains.

Authors:  Q Chen; Y Zhang; D M Johnson; P F Goetinck
Journal:  Mol Biol Cell       Date:  1999-07       Impact factor: 4.138

3.  Tribody: robust self-assembled trimeric targeting ligands with high stability and significantly improved target-binding strength.

Authors:  Dongwook Kim; Sang Kyun Kim; C Alexander Valencia; Rihe Liu
Journal:  Biochemistry       Date:  2013-10-03       Impact factor: 3.162

4.  Native chick laminin-4 containing the beta 2 chain (s-laminin) promotes motor axon growth.

Authors:  R Brandenberger; R A Kammerer; J Engel; M Chiquet
Journal:  J Cell Biol       Date:  1996-12       Impact factor: 10.539

5.  A new animal model for relapsing polychondritis, induced by cartilage matrix protein (matrilin-1).

Authors:  A S Hansson; D Heinegård; R Holmdahl
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

6.  Heteronuclear NMR assignments and secondary structure of the coiled coil trimerization domain from cartilage matrix protein in oxidized and reduced forms.

Authors:  R Wiltscheck; R A Kammerer; S A Dames; T Schulthess; M J Blommers; J Engel; A T Alexandrescu
Journal:  Protein Sci       Date:  1997-08       Impact factor: 6.725

7.  The extracellular domain of immunodeficiency virus gp41 protein: expression in Escherichia coli, purification, and crystallization.

Authors:  P T Wingfield; S J Stahl; J Kaufman; A Zlotnick; C C Hyde; A M Gronenborn; G M Clore
Journal:  Protein Sci       Date:  1997-08       Impact factor: 6.725

8.  Doxorubicin-triggered self-assembly of native amphiphilic peptides into spherical nanoparticles.

Authors:  Xiaobo Fan; Fengfeng Zhao; Xiyong Wang; Guoqiu Wu
Journal:  Oncotarget       Date:  2016-09-06

9.  Heptameric targeting ligands against EGFR and HER2 with high stability and avidity.

Authors:  Dongwook Kim; Yitang Yan; C Alexander Valencia; Rihe Liu
Journal:  PLoS One       Date:  2012-08-09       Impact factor: 3.240

Review 10.  Peptide-Based Treatment: A Promising Cancer Therapy.

Authors:  Yu-Feng Xiao; Meng-Meng Jie; Bo-Sheng Li; Chang-Jiang Hu; Rui Xie; Bo Tang; Shi-Ming Yang
Journal:  J Immunol Res       Date:  2015-10-19       Impact factor: 4.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.